DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Bardoxolone is an investigational drug.
There have been 27 clinical trials for Bardoxolone. The most recent clinical trial was a Phase 2 trial, which was initiated on April 18th 2017.
The most common disease conditions in clinical trials are Kidney Diseases, Renal Insufficiency, Chronic, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Reata Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd., and Kyowa Hakko Kirin Co., Ltd.
There are nineteen US patents protecting this investigational drug and ninety international patents.
Recent Clinical Trials for Bardoxolone
|Phase I Study of RTA 402 in Obese Adults||Kyowa Kirin Co., Ltd.||Phase 1|
|A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON||Reata Pharmaceuticals, Inc.||Phase 3|
|A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults||Kyowa Kirin Co., Ltd.||Phase 1|
Top disease conditions for Bardoxolone
Top clinical trial sponsors for Bardoxolone
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Bardoxolone||See Pricing||Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole||Trustees of Dartmouth College (Hanover, NH)||See Pricing|
|Bardoxolone||See Pricing||Compositions and methods for restoring the stratum corneum and treating dermatological diseases||New York University (New York, NY) BIOKEYS FOR FLAVORS, LLC (Norwood, NJ)||See Pricing|
|Bardoxolone||See Pricing||Inhibitors and methods of use thereof||The Trustees of Dartmounth College (Hanover, NH)||See Pricing|
|Bardoxolone||See Pricing||CDDO-compounds and combination therapies thereof||The Trustees of Dartmouth College (Hanover, NH) Board of Regents, The University of Texas System (Austin, TX)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Bardoxolone||World Intellectual Property Organization (WIPO)||2016033132||2034-08-26||See Pricing|
|Bardoxolone||World Intellectual Property Organization (WIPO)||2012170467||2031-06-07||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|